BCI Marketplace
Depression Neuromodulation trials

Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder

RecruitingNCT06142955Phase: NAStarted 2024-04-30

Summary

This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potential of TMS as an intervention for depression in individuals with Autism Spectrum Disorder (ASD).

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
40 Years

Inclusion Criteria: * Individuals from Yale University and the surrounding community who are between the ages of 18 and 40 years old with or without a diagnosis of depression. Or individuals between the ages of 18 and 40 years old with a diagnosis of autism spectrum disorder, autistic disorder, PDD

Locations

Yale Psychiatric Hospital
New Haven, Connecticut, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →